Page last updated: 2024-10-30

mebendazole and Leukemia

mebendazole has been researched along with Leukemia in 2 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spagnuolo, PA1
Hu, J1
Hurren, R1
Wang, X1
Gronda, M1
Sukhai, MA1
Di Meo, A1
Boss, J1
Ashali, I1
Beheshti Zavareh, R1
Fine, N1
Simpson, CD1
Sharmeen, S1
Rottapel, R1
Schimmer, AD1
Delatour, P1
Lorgue, G1
Lapras, M1
Richard, Y1

Other Studies

2 other studies available for mebendazole and Leukemia

ArticleYear
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma.
    Blood, 2010, Jun-10, Volume: 115, Issue:23

    Topics: Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Cell Death; Cell Survival; Dose-Re

2010
[Embryotoxic and antimitotic properties of parbendazole, mebendazole and cambendazole].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1976, Feb-02, Volume: 282, Issue:5

    Topics: Abnormalities, Drug-Induced; Animals; Benzimidazoles; Cambendazole; Carcinoma, Ehrlich Tumor; Embryo

1976